Patient receives HNP401 through IV 60 minutes before surgery begins.
Illuminated nerves visible to the surgical team during patient surgery.
HNP401 is cleared through kidneys and gone from body in hours.
It is based on our Original Nerve Peptide (NP41) which has shown excellent nerve labeling in laboratory rodents. We are currently in the preclinical phase seeking to bring this technology to market, and hope to begin clinical trials with humans within the next 18 months.
cases involving urinary systems per year
cases involving facelift / facial nerve cancer surgeries per year
cases involving ear surgery per year
cases involving thyroid / parathyroid surgeries per year
Axillary Lymph Node Surgery (breast cancer)
Cervical Neck Dissection (head and neck cancer)
Lateral Approach (spinal surgery)
Repair of Traumatic Nerve Injury